Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy

Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy

We have performed the fi rst-ever pharmacoeconomic analysis in a Russian context of botulin toxin drugs as part of combined therapy for juvenile cerebral palsy (JCP) compared to standard clinical practice. Along with health economic modelling, an analysis of “routine clinical practice” was conducted...

Full description

Bibliographic Details
Main Authors:	A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Format:	Article
Language:	Russian
Published:	Izdatelstvo OKI 2018-06-01
Series:	Качественная клиническая практика
Subjects:	детский церебральный паралич ботулинический токсин типа а ботокс фармакоэкономика затраты анкетирование
Online Access:	https://www.clinvest.ru/jour/article/view/193

Similar Items

Type A botulinum toxin in combined rehabilitation of infantile cerebral paralysis children and teenagers
by: Ye. A. Kislyakova, et al.
Published: (2008-09-01)

Economic analysis of the effectiveness of complex rehabilitation in children with spastic forms of cerebral palsy with injections of botulinum neurotoxin type A and without it
by: V. A. Zmanovskaya, et al.
Published: (2018-07-01)

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis
by: A. S. Kolbin, et al.
Published: (2018-06-01)

Virtual reality technologies in complex medical rehabilitation of patients with cerebral palsy
by: N. N. Karyakin, et al.
Published: (2020-07-01)

The application of MR morphometry of the brain in patients with spastic forms of cerebral palsy in order to determine the predictors of the diagnosis of cerebral palsy and the presence of a unilateral form
by: E. A. Kliuev, et al.
Published: (2022-04-01)

DETERMINATION OF INDIVIDUAL FEATURES OF BALANCE RETAINING IN PATIENTS WITH CEREBRAL PALSY USING STABILOMETRY TESTING
by: O. D. Davydov, et al.
Published: (2014-10-01)

Value of patology of the vestibular analyzer in pathogenesis impellent frustration in children with cerebral paralyses
by: B. M. Glukhov
Published: (2009-06-01)

HIPPOTHERAPY EFFECT IN THE PSYCHOLOGICAL EDUCATIONAL REHABILITAITION OF CHILDREN WITH CEREBRAL PALSY
by: L. S. Chesnokova
Published: (2017-09-01)

Острая и хроническая боль у невербальных детей с неврологической патологией. Возможности диагностики и лечения. Обзор литературы
by: Андрей Викторович Диордиев, et al.
Published: (2019-03-01)

On the absence of interchangeability of botulinum toxin type A drugs
by: A. R. Artemenko, et al.
Published: (2015-12-01)

ОБОСНОВАНИЕ НЕОБХОДИМОСТИ АДАПТИВНОЙ ОДЕЖДЫ ДЛЯ ДЕТЕЙ-ИНВАЛИДОВ
Published: (2021-12-01)

Influence of kyphosis correction in thoracolumber spine on physical activity of children with infantile cerebral palsy
by: V. V. Umnov, et al.
Published: (2016-09-01)

Modern approaches of the cerebral palsy pathogenesis in the substantiation of program for its early diagnosis and treatment introduction
by: L. A. Anaeva, et al.
Published: (2015-08-01)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021-04-01)

ОБОСНОВАНИЕ ВЫБОРА МАТЕРИАЛА ДЛЯ ИЗГОТОВЛЕНИЯ АДАПТИВНОЙ НАТЕЛЬНОЙ ОДЕЖДЫ ДЕТЕЙ-ИНВАЛИДОВ
Published: (2022-04-01)

State of maxillodental system in children with children's cerebral infantile paralysis
by: B. N. Mirchuk, et al.
Published: (2015-02-01)

Neurovisualization features of brain anatomy in children with spastic cerebral palsy revealed by magnetic resonance tractography
by: E. A. Klyuev, et al.
Published: (2021-10-01)

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus
by: A. S. Kolbin, et al.
Published: (2021-02-01)

Pharmacoeconomic analysis of botulinum toxins as treatment for treatment of adult upper limb spasticity
by: Dmitry Belousov, et al.
Published: (2019-04-01)

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Endocardial botulinum toxin injection into ganglionated plexi in order to reduce atrial fibrillation inducibility
by: А. Г. Стрельников, et al.
Published: (2016-01-01)

Neurotoxic denervation of the left atrium for atrial fibrillation treatment and prevention: an experimental animal study
by: А. Г. Стрельников, et al.
Published: (2015-10-01)

Локомоторный профиль сократительного ресурса мышц у больных ДЦП и здоровых сверстников
by: Дмитрий Владимирович Долганов, et al.
Published: (2023-10-01)

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2019-04-01)

Pharmacoeconomics of spastic cerebral palsy
by: R. I. Yagudina, et al.
Published: (2018-02-01)

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Neurological outcomes in preterm infants by age three (observed in a specialized center)
by: E. S. Sakharova, et al.
Published: (2015-12-01)

Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion
by: A. S. Kolbin, et al.
Published: (2018-05-01)

The main approaches to the knee joint stabilization in patients with cerebral palsy
by: V. V. Umnov
Published: (2013-09-01)

Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
by: A. S. Kolbin, et al.
Published: (2018-06-01)

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic study of the effectiveness of cytogenetic studies in patients with MM before prescribing first-line therapy
by: Yu. A. Zabolotneva, et al.
Published: (2024-02-01)

Features of somatic pathology in children with low, very low and extremely low birth weight at different ages of life (review of the world literature)
by: L. S. Namasov-Baranova, et al.
Published: (2016-10-01)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Age-related and Gender Characteristics of the Content of Subjective Experiences of Mental States in Children with Developmental Disorders
by: Лира В. Артищева
Published: (2020-01-01)

Клинико-экономическая оценка антибактериальной терапии интраабдоминальных инфекций
Published: (2018-06-01)

Клинико-экономическая оценка эффективности лечения больных с эпилепсией
Published: (2018-06-01)

Risk factors analysis for early childhood caries
by: O. M. Davidian, et al.
Published: (2021-12-01)

Health technology assessment of colorectal cancer chemotherapy with afl ibercept
by: A. S. Kolbin, et al.
Published: (2018-05-01)